نتائج البحث - "Priscilla Hollander"

1

دورية أكاديمية

Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy.

المؤلفون: Allen B. King, Manuel Muñoz-Torres, Priscilla Hollander, Alan J. Garber, S. Sreenan, Julio Rosenstock, S. Del Prato, Mustafa Kemal Balci, Charlotte T. Hansen, M. Niemeyer

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Internal Medicine

العلاقة: url:https://www.openaccessrepository.it/communities/itmirrorTest; https://www.openaccessrepository.it/record/103689Test

الإتاحة: https://doi.org/10.1111/dom.12411Test
https://www.openaccessrepository.it/record/103689Test

View record in BASE

2

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial

المؤلفون: Raymond L. H. Lam, Julio Rosenstock, Wendy L. Carofano, Roy Eldor, Gregory T. Golm, Philip Home, Baptist Gallwitz, Michael C. Marcos, Priscilla Hollander, Michael F. Crutchlow

المصدر: Diabetes, Obesity and Metabolism. 20:2220-2228

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Insulin Antibodies, Endocrinology, Diabetes and Metabolism, Insulin Glargine, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Least-Squares Analysis, Adverse effect, Glycated Hemoglobin, Type 1 diabetes, Dosing algorithm, business.industry, Insulin glargine, nutritional and metabolic diseases, Middle Aged, medicine.disease, Hypoglycemia, Clinical trial, Diabetes Mellitus, Type 1, Treatment Outcome, Basal (medicine), Tolerability, Female, lipids (amino acids, peptides, and proteins), Open label, business, Algorithms, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58ff53d3128cdeebf56d91c4bad422cTest
https://doi.org/10.1111/dom.13354Test

3

Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100

المؤلفون: Cynthia J. Harris, Jacek Kiljanski, Erik Spaepen, Priscilla Hollander

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, medicine.medical_specialty, Post hoc, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Insulin Glargine, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Therapy naive, self‐titration, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, In patient, Aged, Insulin glargine, business.industry, Incidence (epidemiology), Basal insulin, Incidence, nutritional and metabolic diseases, Original Articles, Middle Aged, medicine.disease, Hypoglycemia, Self Care, Diabetes Mellitus, Type 2, Female, Original Article, Open label, business, Algorithms, medicine.drug, hypoglycaemia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73dd7fe512a12795eeb7ca6a372ebbb3Test
https://pubmed.ncbi.nlm.nih.gov/31264764Test

4

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials

المؤلفون: H. Solberg, Priscilla Hollander, O. Kinduryte, T. Johansen, Jochen Seufert, Jiten Vora

المصدر: Diabetes, Obesity & Metabolism

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d433bdde3d4c4f3803e878a3e4bdba8Test
https://doi.org/10.1111/dom.12621Test

5

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

المؤلفون: Thomas Blevins, Steve Edelman, R. A. Ortmann, Timothy M. Costigan, Melvin J. Prince, J. S. Zielonka, Mark A. Deeg, Robert J. Konrad, Liza L. Ilag, Robyn K. Pollom, W. J. Huster, Priscilla Hollander

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: medicine.medical_specialty, LY2963016 insulin glargine, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Insulin Antibodies, Insulin Glargine, 030209 endocrinology & metabolism, Insulin Antibody, 030204 cardiovascular system & hematology, Hypoglycemia, Cross Reactions, Drug Hypersensitivity, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Double-Blind Method, Internal medicine, Insulin, Regular, Human, Internal Medicine, medicine, Humans, Hypoglycemic Agents, In patient, Immunogenetic Phenomena, Biosimilar Pharmaceuticals, business.industry, Insulin glargine, Immunogenicity, Incidence, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, Cross reactions, Original Articles, medicine.disease, Recombinant Proteins, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hyperglycemia, Asymptomatic Diseases, Original Article, insulin antibody, business, biosimilar insulin, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7cd1d91c5af5483c4f4d9e304aab47Test
http://europepmc.org/articles/PMC4737399Test

6

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

المؤلفون: Gregory T. Golm, Roy Eldor, Wendy L. Carofano, Priscilla Hollander, Raymond L. H. Lam, Baptist Gallwitz, Julio Rosenstock, Michael F. Crutchlow, Marc Rendell, Philip Home, Michael C. Marcos

المصدر: Diabetes, obesitymetabolism. 20(9)

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin Antibodies, Insulin Glargine, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, cardiovascular diseases, Least-Squares Analysis, Adverse effect, Aged, Glycated Hemoglobin, Insulin glargine, business.industry, Insulin, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Hypoglycemia, Clinical trial, Treatment Outcome, Tolerability, Diabetes Mellitus, Type 2, lipids (amino acids, peptides, and proteins), Female, Open label, business, hormones, hormone substitutes, and hormone antagonists, Algorithms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96a8b328630c8bc2c369cf6bebca094Test
https://pubmed.ncbi.nlm.nih.gov/29761615Test

7

المؤلفون: Robyn K. Pollom, Liza L. Ilag, Julio Rosenstock, J. S. Zielonka, Priscilla Hollander, Melvin J. Prince, Anuj Bhargava, W. J. Huster

المصدر: Diabetes, Obesity and Metabolism. 17:734-741

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dfb5347406bc2fb59ea43f7faff6e254Test
https://doi.org/10.1111/dom.12482Test

8

Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial

المؤلفون: Julio Rosenstock, Ngozi Erondu, Harold E. Bays, Albert Fung, Priscilla Hollander, Frank Vercruysse, Mary Ellen Frustaci

المصدر: Diabetes care. 40(5)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0613ad478063b93ad2c8bb4fa3328c3Test
https://pubmed.ncbi.nlm.nih.gov/28289041Test

9

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

المؤلفون: Frank Vercruysse, Guillaume Charpentier, John P.H. Wilding, Gordon Law, Priscilla Hollander, Gary Meininger, Guillermo Gonzalez-Galvez, William Canovatchel, S. Black, Chantal Mathieu, Keith Usiskin

المصدر: International Journal of Clinical Practice

مصطلحات موضوعية: Blood Glucose, Male, endocrine system diseases, Blood Pressure, law.invention, Endocrinology, Randomized controlled trial, Glucosides, law, Weight loss, Insulin-Secreting Cells, Canagliflozin, Aged, 80 and over, General Medicine, Middle Aged, Metformin, Treatment Outcome, Female, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Thiophenes, Placebo, Drug Administration Schedule, Young Adult, Double-Blind Method, Diabetes mellitus, Internal medicine, Weight Loss, medicine, Humans, Hypoglycemic Agents, Adverse effect, Aged, Hemoglobin A, Glycosylated, Glycated Hemoglobin, Dose-Response Relationship, Drug, business.industry, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, medicine.disease, Lipid Metabolism, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, business

وصف الملف: Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a821c022ef94271cbd9478662ad4ecd8Test
http://europepmc.org/articles/PMC4282288Test

10

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes

المؤلفون: Priscilla Hollander, Marek Demissie, Luigi F. Meneghini, A. Nazeri, J. Kesavadev

المصدر: Diabetes, Obesity and Metabolism. 15:729-736

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Argentina, Insulin Glargine, Type 2 diabetes, Rate ratio, Gastroenterology, Drug Administration Schedule, Body Mass Index, Endocrinology, Insulin Detemir, Internal medicine, Republic of Korea, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin detemir, Glycated Hemoglobin, business.industry, Insulin glargine, Insulin, Body Weight, nutritional and metabolic diseases, Fasting, Middle Aged, Thailand, medicine.disease, Hypoglycemia, Metformin, United States, Insulin, Long-Acting, Treatment Outcome, Diabetes Mellitus, Type 2, Patient Satisfaction, Drug Therapy, Combination, Female, Once daily, medicine.symptom, business, Weight gain, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5539d6230a2c1cb1a7a5727e8df54040Test
https://doi.org/10.1111/dom.12083Test

تنقيح النتائج